|
|
Volumn 37, Issue 4, 2000, Pages 367-380
|
|
Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
|
|
Author keywords
5 dihydrotestosterone; 5 reductase inhibitors; Finasteride; GI198745 (dual 5 reductase inhibitor); Human benign prostatic hyperplasia
|
|
Indexed keywords
4 [2 [4 (4 ISOBUTYL ALPHA METHYLBENZYLOXY) 2,3 DIMETHYLBENZAMIDO]PHENOXY]BUTYRIC ACID;
ANDROGEN;
ANDROSTANOLONE;
ANTIANDROGEN;
AZASTEROID;
BICALUTAMIDE;
CYPROTERONE ACETATE;
DUTASTERIDE;
EPRISTERIDE;
FINASTERIDE;
FLUTAMIDE;
GROWTH FACTOR;
ISOENZYME;
METRIBOLONE;
NILUTAMIDE;
SKF 105687;
STEROID 5ALPHA REDUCTASE INHIBITOR;
TESTOSTERONE;
UNCLASSIFIED DRUG;
ENZYME INHIBITOR;
STEROID 5ALPHA REDUCTASE;
AGING;
ANDROGEN BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SPECIFICITY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
ENZYME LOCALIZATION;
FOLLOW UP;
GROWTH REGULATION;
HUMAN;
IMPOTENCE;
MALE SEXUAL DYSFUNCTION;
MALE TYPE ALOPECIA;
MORPHOLOGY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE EPITHELIUM;
PROSTATE HYPERTROPHY;
PROSTATE SURGERY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SEBACEOUS GLAND;
STRUCTURE ACTIVITY RELATION;
TESTOSTERONE BLOOD LEVEL;
TESTOSTERONE METABOLISM;
URINARY TRACT OBSTRUCTION;
AGED;
DRUG ANTAGONISM;
ENZYMOLOGY;
MALE;
METABOLISM;
MIDDLE AGED;
PROGNOSIS;
SENSITIVITY AND SPECIFICITY;
AGED;
AGING;
CLINICAL TRIALS;
DIHYDROTESTOSTERONE;
ENZYME INHIBITORS;
FINASTERIDE;
HUMANS;
MALE;
MIDDLE AGED;
PROGNOSIS;
PROSTATIC HYPERPLASIA;
SENSITIVITY AND SPECIFICITY;
TESTOSTERONE 5-ALPHA-REDUCTASE;
|
|
EID: 0033625134
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000020181 Document Type: Review |
|
Times cited : (170)
|
|
References (112)
|
